---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-017044"
form_type: "8-K"
ticker: "OMER"
cik: "0001285819"
company_name: "OMEROS CORP"
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T22:45:36.310145+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Omeros Q1 net loss $37.2M; cash extends into 2026 after $115.5M royalty deal

## Summary
- Net loss $37.2M ($0.63/share) vs $33.7M ($0.54) in Q1 2023; loss from cont ops $43.9M vs $39.7M.
- Cash + short-term investments $230.3M at Mar 31, up $58.5M from Dec 31; includes $115.5M from DRI royalty deal.
- Sold DRI expanded OMIDRIA royalty: DRI gets all US royalties through 2031; Omeros retains ex-US & post-2031 global; potential milestones up to $27.5M each.
- OMS906 Phase 2 PNH data at EHA June 15; Phase 3 start late 2024. Narsoplimab BLA resubmission timeline uncertain pending FDA.
- Repurchased 3.2M shares for $11.9M in Q1.

## SEC filing metadata
- accession: 0001437749-24-017044
- form_type: 8-K
- ticker: OMER
- cik: 0001285819
- company_name: OMEROS CORP
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285819/000143774924017044/0001437749-24-017044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285819/000143774924017044/omer20240415_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-017044
- JSON: https://secwatch.observer/filing/0001437749-24-017044.json
- Plain text: https://secwatch.observer/filing/0001437749-24-017044.txt

## Key facts
- Earnings Releases
  OMEROS CORP reported the first quarter ended March 31, 2024 results: net income Net loss for the first quarter of 2024 was $37.2 million, or $0.63 per share, EPS $0.63 per share.
  - Period: the first quarter ended March 31, 2024
  - Net income: Net loss for the first quarter of 2024 was $37.2 million, or $0.63 per share
  - EPS: $0.63 per share
  - Result: reported results
  source text: Omeros Corporation Reports First Quarter 2024 Financial Results
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285819/000143774924017044/0001437749-24-017044-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.